-
Something wrong with this record ?
In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo
H. Bártíková, I. Vokřál, L. Skálová, J. Lamka, B. Szotáková
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Albendazole analogs & derivatives metabolism pharmacokinetics pharmacology MeSH
- Biotransformation drug effects MeSH
- Dicrocoelium drug effects enzymology metabolism MeSH
- Glutathione Peroxidase metabolism MeSH
- Enzyme Inhibitors pharmacology MeSH
- Sheep parasitology MeSH
- Oxidation-Reduction drug effects MeSH
- Subcellular Fractions drug effects enzymology MeSH
- Xenobiotics metabolism MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Dicrocoeliosis, a parasitic infection caused by Dicrocoelium dendriticum (lancet fluke), is often treated by the anthelmintic drug albendazole (ABZ). In the lancet fluke, ABZ metabolism via enzymatic sulphoxidation was found, but no information about ABZ oxidases has been available. The aim of our project was to find out which enzyme of the lancet fluke is responsible for ABZ sulphoxidation, as well as to assay the activities of oxidation enzymes. We also studied whether ex vivo 24-h exposures of flukes to ABZ or its sulphoxide (ABZ.SO) would alter ABZ sulphoxidation rate and the activities of tested enzymes. In subcellular fractions from flukes, marked activities of peroxidase (Px), glutathione Px (GPx), catalase (CAT), superoxide dismutase, and thioredoxin glutathione reductase were found. Using specific inhibitors, the participation of flavine monooxygenases in ABZ-oxidation was found. The ex vivo exposition of flukes to ABZ or ABZ.SO did not change the rate of ABZ sulphoxidation in vitro, but the ex vivo exposure of flukes to anthelmintics increased Px, CAT, and GPx activity. The modulation of these enzyme activities after ABZ or ABZ.SO exposition may be characteristic of the parasite’s protective mechanism against oxidative stress caused by drug treatment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027407
- 003
- CZ-PrNML
- 005
- 20160229103328.0
- 007
- ta
- 008
- 120816s2010 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.3109/00498254.2010.497565 $2 doi
- 035 __
- $a (PubMed)20560773
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bártíková, H $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic $7 xx0335122
- 245 10
- $a In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo / $c H. Bártíková, I. Vokřál, L. Skálová, J. Lamka, B. Szotáková
- 520 9_
- $a Dicrocoeliosis, a parasitic infection caused by Dicrocoelium dendriticum (lancet fluke), is often treated by the anthelmintic drug albendazole (ABZ). In the lancet fluke, ABZ metabolism via enzymatic sulphoxidation was found, but no information about ABZ oxidases has been available. The aim of our project was to find out which enzyme of the lancet fluke is responsible for ABZ sulphoxidation, as well as to assay the activities of oxidation enzymes. We also studied whether ex vivo 24-h exposures of flukes to ABZ or its sulphoxide (ABZ.SO) would alter ABZ sulphoxidation rate and the activities of tested enzymes. In subcellular fractions from flukes, marked activities of peroxidase (Px), glutathione Px (GPx), catalase (CAT), superoxide dismutase, and thioredoxin glutathione reductase were found. Using specific inhibitors, the participation of flavine monooxygenases in ABZ-oxidation was found. The ex vivo exposition of flukes to ABZ or ABZ.SO did not change the rate of ABZ sulphoxidation in vitro, but the ex vivo exposure of flukes to anthelmintics increased Px, CAT, and GPx activity. The modulation of these enzyme activities after ABZ or ABZ.SO exposition may be characteristic of the parasite’s protective mechanism against oxidative stress caused by drug treatment.
- 650 _2
- $a albendazol $x analogy a deriváty $x metabolismus $x farmakokinetika $x farmakologie $7 D015766
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biotransformace $x účinky léků $7 D001711
- 650 _2
- $a Dicrocoelium $x účinky léků $x enzymologie $x metabolismus $7 D004013
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a glutathionperoxidasa $x metabolismus $7 D005979
- 650 _2
- $a oxidace-redukce $x účinky léků $7 D010084
- 650 _2
- $a ovce $x parazitologie $7 D012756
- 650 _2
- $a subcelulární frakce $x účinky léků $x enzymologie $7 D013347
- 650 _2
- $a xenobiotika $x metabolismus $7 D015262
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vokřál, Ivan $7 _AN067830 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Skálová, Lenka, $d 1965- $7 mzk2004230464 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Lamka, Jiří, $d 1953- $7 nlk19990073481 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Szotáková, Barbora $7 jx20070426012 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 773 0_
- $w MED00004746 $t Xenobiotica; the fate of foreign compounds in biological systems $x 1366-5928 $g Roč. 40, č. 9 (2010), s. 593-601
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20560773 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160229103045 $b ABA008
- 999 __
- $a ok $b bmc $g 949449 $s 784753
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 40 $c 9 $d 593-601 $i 1366-5928 $m Xenobiotica $n Xenobiotica $x MED00004746
- LZP __
- $b NLK112 $a Pubmed-20120816/11/02